Cargando…
Investigation of anti-diabetic potential and molecular simulation studies of dihydropyrimidinone derivatives
In an attempt to find new targets for α-amylase and α-glucosidase for the treatment of type 2 diabetes mellitus, the present study aims in determining the anti-diabetic potential of synthesized dihydropyrimidinone derivatives. The in vitro α-glucosidase and α-amylase inhibitory activity was performe...
Autores principales: | Ilyas, Umair, Nazir, Bisma, Altaf, Reem, Muhammad, Syed Aun, Zafar, Hajra, Paiva-Santos, Ana Cláudia, Abbas, Muhammad, Duan, Yongtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596752/ https://www.ncbi.nlm.nih.gov/pubmed/36313779 http://dx.doi.org/10.3389/fendo.2022.1022623 |
Ejemplares similares
-
A meta-analysis of genome-wide gene expression differences identifies promising targets for type 2 diabetes mellitus
por: Huang, Tao, et al.
Publicado: (2022) -
Cytotoxic Evaluation, Molecular Docking, and 2D-QSAR Studies of Dihydropyrimidinone Derivatives as Potential Anticancer Agents
por: Altaf, Reem, et al.
Publicado: (2022) -
Synthesis, Biological Evaluation, 2D-QSAR, and Molecular
Simulation Studies of Dihydropyrimidinone Derivatives as Alkaline
Phosphatase Inhibitors
por: Altaf, Reem, et al.
Publicado: (2022) -
Recent advances in immune checkpoint inhibitors for non-small lung cancer treatment
por: Altaf, Reem, et al.
Publicado: (2022) -
Nanostructured Lipid Carrier-Based Delivery of Pioglitazone for Treatment of Type 2 Diabetes
por: Ilyas, Umair, et al.
Publicado: (2022)